Paradigm Biopharmaceuticals Limited logo

Paradigm Biopharmaceuticals Limited

ASX:PAR.AX

Overview | Financials
Company Name Paradigm Biopharmaceuticals Limited
Symbol PAR.AX
Currency AUD
Price 0.455
Market Cap 177,190,195
Dividend Yield 0%
52-week-range 0.165 - 0.66
Industry Biotechnology
Sector Healthcare
CEO Mr. Paul John Rennie BSc, Grad Dip, MBM, MSTC
Website https://www.paradigmbiopharma.com

An error occurred while fetching data.

About Paradigm Biopharmaceuticals Limited

Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, and acute respiratory distress syndrome diseases. The company

Related Stocks

Pacific Smiles Group Limited logo

Pacific Smiles Group Limited

PSQ.AX

1.68 AUD

Rhythm Biosciences Limited logo

Rhythm Biosciences Limited

RHY.AX

0.052 AUD

Race Oncology Limited logo

Race Oncology Limited

RAC.AX

1.185 AUD

Aroa Biosurgery Limited logo

Aroa Biosurgery Limited

ARX.AX

0.575 AUD

Cogstate Limited logo

Cogstate Limited

CGS.AX

1.65 AUD

Anteris Technologies Ltd logo

Anteris Technologies Ltd

AVR.AX

5.62 AUD

Starpharma Holdings Limited logo

Starpharma Holdings Limited

SPL.AX

0.092 AUD

PYC Therapeutics Limited logo

PYC Therapeutics Limited

PYC.AX

1.32 AUD

AnteoTech Limited logo

AnteoTech Limited

ADO.AX

0.013 AUD

Paragon Care Limited logo

Paragon Care Limited

PGC.AX

0.39 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD